{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:24:00Z","timestamp":1782739440637,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Putian City Science and Technology Plan Project","award":["2021S2001-9"],"award-info":[{"award-number":["2021S2001-9"]}]},{"name":"Project Approved by Fujian Shanhe Pharmaceutical Co., LTD","award":["2022AHX211(L)"],"award-info":[{"award-number":["2022AHX211(L)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34583-2","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:06:59Z","timestamp":1767798419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesis and biological evaluation, network pharmacology, and molecular docking of 2-benzylidene-1-indanone derivatives as antitumor agents"],"prefix":"10.1038","volume":"16","author":[{"given":"Xuemei","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangting","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beidou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"34583_CR1","doi-asserted-by":"publisher","first-page":"111687","DOI":"10.1016\/j.ejmech.2019.111687","volume":"183","author":"M Hossain","year":"2019","unstructured":"Hossain, M. et al. Recent advances in alpha, beta-unsaturated carbonyl compounds as mitochondrial toxins. Eur. J. Med. Chem. 183, 111687 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"34583_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/B978-0-444-63932-5.00008-5","volume":"51","author":"N Ahmed","year":"2016","unstructured":"Ahmed, N. Synthetic advances in the Indane natural product scaffolds as drug candidates: a review. Stud. Nat. Prod. Chem. 51, 383\u2013434 (2016).","journal-title":"Stud. Nat. Prod. Chem."},{"issue":"8","key":"34583_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.ejmech.2007.10.023","volume":"43","author":"LM Finkielsztein","year":"2008","unstructured":"Finkielsztein, L. M. et al. New 1-indanone thiosemicarbazone derivatives active against BVDV. Eur. J. Med. Chem. 43 (8), 1767\u20131773 (2008).","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"34583_CR4","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1021\/jo0483724","volume":"70","author":"E Fillion","year":"2005","unstructured":"Fillion, E. et al. Meldrum\u2019s acids as acylating agents in the catalytic intramolecular Friedel-Crafts reaction. J. Org. Chem. 70 (4), 1316\u20131327 (2005).","journal-title":"J. Org. Chem."},{"issue":"26","key":"34583_CR5","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1002\/chem.200700613","volume":"13","author":"J Petrignet","year":"2007","unstructured":"Petrignet, J. et al. Application of the intramolecular isomerisation- aldolisation from allylic alcohols and allylic Silyl ethers to the synthesis of indanones and indenones. Chem. Eur. J. 13 (26), 7374\u20137384 (2007).","journal-title":"Chem. Eur. J."},{"issue":"8","key":"34583_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2174\/1573406413666170330094822","volume":"13","author":"SA Patil","year":"2017","unstructured":"Patil, S. A. et al. Identification of novel 5, 6-dimethoxyindan-1-one derivatives as antiviral agents. Med. Chem. 13 (8), 787\u2013795 (2017).","journal-title":"Med. Chem."},{"issue":"1","key":"34583_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejmech.2008.03.003","volume":"44","author":"R Sheng","year":"2009","unstructured":"Sheng, R. et al. Design, synthesis and ache inhibitory activity of indanone and Aurone derivatives. Eur. J. Med. Chem. 44 (1), 7\u201317 (2009).","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"34583_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/jnci\/92.3.217","volume":"92","author":"LM Leoni","year":"2000","unstructured":"Leoni, L. M. et al. Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells. J. Natl. Cancer I. 92 (3), 217\u2013224 (2000).","journal-title":"J. Natl. Cancer I"},{"key":"34583_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00044-010-9368-4","volume":"20","author":"R Bansal","year":"2011","unstructured":"Bansal, R. et al. Synthesis of some imidazolyl- substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy. Med. Chem. Res. 20, 661\u2013669 (2011).","journal-title":"Med. Chem. Res."},{"issue":"9","key":"34583_CR10","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.bmc.2012.02.057","volume":"20","author":"AP Prakasham","year":"2012","unstructured":"Prakasham, A. P. et al. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization. Bioorg. Med. Chem. 20 (9), 3049\u20133057 (2012).","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"34583_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1039\/C5MD00139K","volume":"6","author":"J Hu","year":"2015","unstructured":"Hu, J. et al. Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents. MedChemComm 6 (7), 1318\u20131327 (2015).","journal-title":"MedChemComm"},{"key":"34583_CR12","doi-asserted-by":"publisher","first-page":"114851","DOI":"10.1016\/j.ejmech.2022.114851","volume":"244","author":"MD Alt\u0131ntop","year":"2022","unstructured":"Alt\u0131ntop, M. D. et al. Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer. Eur. J. Med. Chem. 244, 114851 (2022).","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"34583_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins, A. L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4 (11), 682\u2013690 (2008).","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"34583_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1039\/C5NP00005J","volume":"32","author":"M Kibble","year":"2015","unstructured":"Kibble, M. et al. Network Pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat. Prod. Rep. 32 (8), 1249\u20131266 (2015).","journal-title":"Nat. Prod. Rep."},{"key":"34583_CR15","doi-asserted-by":"publisher","first-page":"156025","DOI":"10.1016\/j.phymed.2024.156025","volume":"135","author":"Q Deng","year":"2024","unstructured":"Deng, Q. et al. Based on network pharmacology, molecular Docking and experimental verification to reveal the mechanism of andrographis paniculata against solar dermatitis. Phytomedicine 135, 156025 (2024).","journal-title":"Phytomedicine"},{"key":"34583_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ejmech.2017.06.018","volume":"137","author":"TM Kadayat","year":"2017","unstructured":"Kadayat, T. M. et al. Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease. Eur. J. Med. Chem. 137, 575\u2013597 (2017).","journal-title":"Eur. J. Med. Chem."},{"issue":"28","key":"34583_CR17","doi-asserted-by":"publisher","first-page":"20339","DOI":"10.1039\/D4RA02797C","volume":"14","author":"C Lei","year":"2024","unstructured":"Lei, C. et al. Synthesis and bioactivity investigation of benzophenone and its derivatives. RSC Adv. 14 (28), 20339\u201320350 (2024).","journal-title":"RSC Adv."},{"key":"34583_CR18","doi-asserted-by":"crossref","unstructured":"Wang, P. et al. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PloS One 5 (4), e10202 (2010).","DOI":"10.1371\/journal.pone.0010202"},{"issue":"1","key":"34583_CR19","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A. et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7 (1), 42717 (2017).","journal-title":"Sci. Rep."},{"issue":"12","key":"34583_CR20","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/ci500467k","volume":"54","author":"A Daina","year":"2014","unstructured":"Daina, A. et al. iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach. J. Chem. Inf. Model. 54 (12), 3284\u20133301 (2014).","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"34583_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina, A. et al. A boiled-egg to predict Gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11 (11), 1117\u20131121 (2016).","journal-title":"ChemMedChem"},{"issue":"W1","key":"34583_CR22","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A. et al. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47 (W1), W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"34583_CR23","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/bioinformatics\/btt540","volume":"29","author":"D Gfeller","year":"2013","unstructured":"Gfeller, D. et al. Shaping the interaction landscape of bioactive molecules. Bioinformatics 29 (23), 3073\u20133079 (2013).","journal-title":"Bioinformatics"},{"key":"34583_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","volume":"30","author":"ZJ Yao","year":"2016","unstructured":"Yao, Z. J. et al. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models. J. Comput. Aid Mol. Des. 30, 413\u2013424 (2016).","journal-title":"J. Comput. Aid Mol. Des."},{"key":"34583_CR25","doi-asserted-by":"crossref","unstructured":"Zhang, X. M. et al. Identification of key mRNAs and signaling pathways in obsessive compulsive disorder based on weighted gene co-expression network analysis and CytoHubba plugin. Brain Behav. 14(5), e3412 (2024).","DOI":"10.1002\/brb3.3412"},{"issue":"1","key":"34583_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13020-023-00818-5","volume":"18","author":"JM Zhuang","year":"2023","unstructured":"Zhuang, J. M. et al. Mechanisms of Xiaozheng Decoction for anti-bladder cancer effects via affecting the GSK3\u03b2\/\u03b2-catenin signaling pathways: a network pharmacology-directed experimental investigation. Chin. Med. 18 (1), 104 (2023).","journal-title":"Chin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34583-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34583-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34583-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:14:49Z","timestamp":1770110089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34583-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34583"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34583-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4581"}}